Long-term follow-up results of anti-BCMA CAR-T cell therapy combined with autologous hematopoietic stem cell transplantation in relapsed/refractory multiple myeloma with extramedullary disease

医学 多发性骨髓瘤 细胞因子释放综合征 造血干细胞移植 内科学 肿瘤科 嵌合抗原受体 队列 入射(几何) 移植 临床试验 自体干细胞移植 胃肠病学 干细胞 骨髓 疾病 回顾性队列研究 免疫疗法 免疫系统 免疫学 外科 累积发病率 细胞疗法 抗体 总体生存率 抗原 挽救疗法 病理 造血 梅尔法兰
作者
Xin Li,Can Liu,Siyan Niu,Ru Li,Shuquan Gao,Rui Cui,Jia Wang,Yao Qi,Jingyi Li,Qi Deng
出处
期刊:Journal of Translational Medicine [BioMed Central]
卷期号:24 (1) 被引量:1
标识
DOI:10.1186/s12967-026-08302-y
摘要

BACKGROUND: Relapsed/refractory multiple myeloma (R/R MM) with extramedullary disease (EMD) has a poor prognosis. Responses to current therapies, including autologous hematopoietic stem cell transplantation (auto-HSCT) and chimeric antigen receptor (CAR) T-cell therapy, remain unsatisfactory or show frequent early progression despite an initial response. In this study, we aimed to investigate the efficacy of a therapeutic approach combining CAR T-therapy with auto-HSCT. METHODS: Eighteen patients with R/R MM with EMD were enrolled in clinical trials evaluating anti-BCMA CAR-T therapy. Of these, eight patients were treated in combination with auto-ASCT in combination (T-C group), while the remaining ten underwent CAR T-cell therapy alone (C group). We retrospectively compared the clinical responses, CAR T-cell expansion kinetics, T-cell subset profiles, serum interleukin-6 (IL-6) levels, treatment-related toxicities, and long-term outcomes between the two cohorts. RESULTS: In the T-C group, all 8 patients achieved an overall response (ORR) (ORR) based on the combined haematologic and imaging assessments of EMD. In contrast, among the 10 patients in the C group, 8 met the haematologic criteria for ORR, but only 6 demonstrated a radiographic response in EMD lesions. Progression-free survival (PFS) and overall survival (OS) were markedly improved in the T-C group. This cohort also exhibited higher peak levels of both CAR- T cells and IL-6. On day 28 post-infusion, the proportion of CD3⁺CD4⁺ T cells was significantly higher in the T-C group. While cytokine release syndrome (CRS) tended to be more severe in this group, the incidence and severity of the immune effector cell-associated neurotoxicity syndrome (ICANS) was comparable between the two groups. Haematologic recovery was delayed in the T-C group, and three of the eight patients developed poor graft function. CONCLUSION: We retrospectively summarised the results of a 3-year follow-up and found that the combination of anti-BCMA CAR-T cell therapy and auto-HSCT was associated with improved PFS and OS in R/R MM patients with EMD. Moreover, CD4⁺ T-cell dynamics may be associated with the durable clinical response observed in the T-C group. Although the T-C group experienced higher-grade CRS and prolonged haematological toxicity, no treatment-related deaths due to treatment-related toxicities were observed. (Trial registration: ChiCTR2000033925). TRIAL REGISTRATION: Registration center: Tianjin First Central Hospital. TRIAL REGISTRATION NUMBER: ChiCTR2000033925. Registration Date: June 17, 2020. The patient gave their written informed consent in accordance with the Declaration of Helsinki. The patients agreed to have their data used in our study.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
张大旺发布了新的文献求助10
刚刚
舒心易烟发布了新的文献求助10
刚刚
水煮电吹风的应助被青争采纳,获得10
刚刚
QWJ发布了新的文献求助10
1秒前
炒米粉完成签到,获得积分0
1秒前
Remon完成签到,获得积分10
2秒前
2秒前
yaswer完成签到,获得积分10
3秒前
4秒前
4秒前
4秒前
4秒前
4秒前
风吹半夏完成签到,获得积分10
4秒前
十二十三完成签到 ,获得积分10
5秒前
水煮电吹风的应助被叉叉采纳,获得10
6秒前
7秒前
wzg666完成签到,获得积分10
7秒前
唐鑫完成签到,获得积分10
7秒前
GVD完成签到,获得积分10
8秒前
8秒前
英吉利25发布了新的文献求助10
8秒前
9秒前
9秒前
10秒前
10秒前
愿抒发布了新的文献求助10
10秒前
10秒前
小二郎的应助被和谐如风采纳,获得10
13秒前
13秒前
FashionBoy的应助被科研究极进化采纳,获得10
13秒前
Limerence完成签到,获得积分10
13秒前
14秒前
研友_xLOMQZ发布了新的文献求助30
14秒前
zzzz发布了新的文献求助10
15秒前
李爱国的应助被zww113采纳,获得10
15秒前
丹亦发布了新的文献求助10
15秒前
bkagyin的应助被kgy采纳,获得10
16秒前
17秒前
Sunyidan完成签到,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181888
求助须知:如何正确求助?哪些是违规求助? 9571628
关于积分的说明 21818887
捐赠科研通 7778145
什么是DOI,文献DOI怎么找? 3433528
关于科研通互助平台的介绍 2557710
邀请新用户注册赠送积分活动 2479621